help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/endo-110-6-2011
Endocrinology Vol. 110, No. 6 2011-2017
Copyright © 1982 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SENGA, O.
Right arrow Articles by HILL, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SENGA, O.
Right arrow Articles by HILL, J. B., JR.

Comparison of Peripheral Thyroid Hormone Metabolism in Normal Rats and in Rats Receiving Prolonged Glucagon Infusion*

OSAMU SENGA, CONSTANCE S. PITTMAN, RAYMOND H. LINDSAY, JOSEPH B. CHAMBERS, JR., and JOHN B. HILL, JR.

Birmingham Veterans Administration Medical Center and The University of Alabama in Birmingham School of Medicine, Birmingham, Alabama 35294

Address all correspondence and requests for reprints to: Constance S. Pittman, M.D., Division of Endocrinology and Metabolism, Department of Medicine, University of Alabama in Birmingham School of Medicine, University Station, Birmingham, Alabama 35294.

Abstract

An elevated plasma glucagon concentration and reduced T3 production from T4 have both been observed in several clinical disorders, including hepatic cirrhosis, uremia, diabetes mellitus, and starvation. The question of whether glucagon has a direct effect on T3 production was studied in normal rats infused iv with [125I]T4 or [125I]T3 and 3 µg T4/day, using implanted minipumps. The blood [125I]T4 and [125I]T3 levels maintained a plateau between the fifth and ninth days of infusion. Each animal also received a second minipump, implanted ip, that infused either a diluant solution or 30 µg glucagon/100 g BW· day. After 7 days of continuous infusion, the glucagontreated animals showed a 20% increase in plasma glucose and a 4-fold increase in plasma glucagon from baseline. However, the levels of insulin, T4) and T3 remained unchanged. The MCRs and the disposal rates of T4 and T3) calculated by the constant infusion method, showed T4 and T3 MCRs to be 0.99 ± 0.18 and 11.25 ± 2.52 ml/h-100 g, respectively, and T4 and T3 disposal rates to be 68 ± 10 and 9± 2 ng/h · 100 g; there was no difference between the control animals and the glucagon-infused animals. T3 product on was also determined in vitro from T4 added to a liver homogenate. Compared to control animals, the liver homogenate prepared from glucagon-infused animals showed a modestly higher T3 production rate throughout the 60-min incubation period (P = 0.025-0.05). However, the concentration of nonprotein-bound sulfhydryls was similar in the liver, kidney, brain, muscle, and heart of the two animal groups. In conclusion, glucagon does not have an important regulating role on the peripheral metabolism of thyroid hormone and T3 production in rats.

Footnotes

* This work was supported by the Research Division of the V.A.

Received August 13, 1981.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society